Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/70105
Title: Biodegradable post biopsy breast marker
Authors: Teh, Wen Hui
Keywords: DRNTU::Engineering::Materials
Issue Date: 2017
Abstract: Breast biopsy involves needle extraction of small suspicious lesion breast tissue for diagnosis. A breast marker is inserted subsequently to mark the biopsy site for future targeting and referencing due to the transition of the surrounding tissue after tissue removal and remodeling or healing of tissue around the biopsy site. Currently, metallic markers are available for post breast biopsy and they are stayed permanent should the biopsy test diagnosed as benign. In this study, biodegradable breast marker was proposed as an alternative marker. Prototypes were fabricated with varying composition of Poly (lactic-co-glycolic acid) (PLGA) (in molar ratio 50:50, 75:25 and 82:18) to impart timeframe of degradation in 3, 6 and 9 months and with embedded radiopaque fillers to enhance radiopacity under X-Ray imaging. In vitro degradation of these prototypes was evaluated in term of mass loss and molecular weight. X-ray images on these prototypes throughout the degradation period demonstrated the potential use of formulations for 50:50 and 75:25 up to 1 month while formulation 82:18 had shown consistent visibility up to 9 months. In vivo feasibility study was performed on rabbit breast model, demonstrated good visibility in the initial stage of deployment.  
URI: http://hdl.handle.net/10356/70105
Schools: School of Materials Science and Engineering 
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:MSE Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
Teh Wen Hui_Final FYP Report (MSE16-097).pdf
  Restricted Access
1.45 MBAdobe PDFView/Open

Page view(s) 50

518
Updated on Jan 21, 2025

Download(s) 50

21
Updated on Jan 21, 2025

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.